Breast cancer histologic subtypes show excess familial clustering-Reference-Cited by-同舟云学术

Breast cancer histologic subtypes show excess familial clustering

Published:2019-05-23 Issue:18 Volume:125 Page:3131-3138
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Henry N. Lynn¹²^ORCID,Cannon‐Albright Lisa A.²³⁴^ORCID

Affiliation:

1. Division of Oncology, Department of Internal Medicine University of Utah School of Medicine Salt Lake City Utah

2. Huntsman Cancer Institute Salt Lake City Utah

3. Division of Epidemiology, Department of Internal Medicine University of Utah School of Medicine Salt Lake City Utah

4. George E. Wahlen Department of Veterans Affairs Medical Center Salt Lake City Utah

Funder

National Cancer Institute

Centers for Disease Control and Prevention

Huntsman Cancer Foundation

Huntsman Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32198

Reference24 articles.

1. World Health Organization classification of tumors

2. Genomic, transcriptomic, epigenetic, and immune profiling of mucinous breast cancer [published online February 21, 2019];Nguyen B;J Natl Cancer Inst

3. Mucinous breast carcinomas lack PIK3CA and AKT1 mutations

4. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel immunotherapies for breast cancer: Focus on 2023 findings;International Immunopharmacology;2024-02

2. A ubiquitin–proteasome system-related signature to predict prognosis, immune infiltration, and therapy efficacy for breast cancer;Immunologic Research;2023-12-01

3. Spindle Cell Carcinoma of the Breast in a Patient with Previous History of Rectal Cancer: A Case Report;Forum of Clinical Oncology;2023-10-12

4. Spectrum of Mucin-containing Lesions of the Breast: Multimodality Imaging Review with Pathologic Correlation;RadioGraphics;2023-10-01

5. A Clinical Cognizance of Molecular and Pathological Diagnostic Approach of TNBC;Therapeutic Drug Targets and Phytomedicine For Triple Negative Breast Cancer;2023-01